National Institute of Allergy and Infectious Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial
Thomas A. Murray, Christina E. Barkauskas, Eleftherios E Mylonakis, Daniel Knox et al.
Citations
2 citations
Journal
Clinical Microbiology and Infection
Topics
COVID-19 Clinical Research Studies
Field-Weighted Citation Impact (FWCI)
2.79
article
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial
Thomas A. Murray, Christina E. Barkauskas, Eleftherios E Mylonakis, Daniel Knox, John Williamson, Barnaby Edward Young, Nicole Engen, Jakob J Malin, Adit A. Ginde, Lianne Siegel, Jonathan Kitonsa, Nnakelu Eriobu, Wesley H. Self, Vasiliki Rapti, Tomas Ø. Jensen, Kami Kim, David Price, David M. Vock, Uriel Sandkovsky, Thomas L Holland, Srikanth Ramachandruni, Cavan Reilly, Alfredo J Mena Lora, Mamta K. Jain, Elizabeth S. Higgs, Ahmad Mourad, Jens Dilling Lundgren, G. Mathews, Roger Paredes, Gregory Grandits
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Clinical Microbiology and InfectionVol. 31(6)
Institutions
University of Copenhagen (DK), National Institutes of Health (US), University of Minnesota (US), Duke University (US), University of Cologne (DE), National and Kapodistrian University of Athens (GR), Kiryu University (JP), Royal Victoria Infirmary (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Tampa General Hospital (US), Baylor University Medical Center (US), Mount Elizabeth Novena Hospital (SG), Rigshospitalet (DK), Intermountain Medical Center (US), UNSW Sydney (AU), University of Illinois Chicago (US), University of Chicago (US), Clinical Research Institute (US), Southwestern Medical Center (US), Methodist Hospital (US), CHRISTUS Spohn Hospital Corpus Christi - Memorial (US), Department of Health (TW), Pulmonary and Allergy Associates (US), Institute of Human Virology (NG), Duke Medical Center (US), National Institute of Allergy and Infectious Diseases (US), Minnesota Department of Health (US), National Centre for Infectious Diseases (SG), Hospital Universitari Germans Trias i Pujol (ES), University Hospital Cologne (DE), Centre of Excellence for Health, Immunity and Infections (DK), Sotiria General Hospital (GR), Wake Forest University (US), The University of Texas Southwestern Medical Center (US), Vanderbilt University Medical Center (US), Uganda Virus Research Institute (UG), University of Colorado Denver (US)
Funders
U.S. Department of Health and Human Services, Pfizer, Gilead Sciences, Regeneron Pharmaceuticals, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases